EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry

Christian Gold, Flora Diana Gausz, Anna Vagvolgyi, Florian Hecker, Jana Kupusovic, Marton Miklos, Tamas Szili-Torok, David M Leistner, Reza Wakili, Julia W Erath, Mate Vamos

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-025-02834-x ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Christian Gold und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Goethe University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Obesity, Registries, Electric Countershock. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: none, Johann Wolfgang Goethe-Universität, Frankfurt am Main.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study evaluated the efficacy and safety of the subcutaneous implantable cardioverter defibrillator (S-ICD) in patients with obesity.

Methods

In this bicentric, retrospective study, S-ICD recipients were divided into two groups based on body mass index (BMI: < 30 kg/m 2 and ≥ 30 kg/m 2 ). Defibrillation testing (DFT) failure, shock impedance, rates of appropriate and inappropriate shock, long-term complications, survival, and device-related or cardiac rehospitalizations were compared.

Results

Of the 120 patients included, most baseline characteristics were similar between patients with ( n = 30) and without obesity ( n = 90), except for a higher prevalence of diabetes in the group with obesity. The first shock during DFT was similarly effective (99 vs. 100%), although, shock impedance was significantly higher in patients with obesity (59 vs. 74 Ω; p = 0.011). There was no difference between the groups regarding the incidence of appropriate (hazard ratio [HR] 0.70, 95% confidence interval [CI] 0.21–2.34, p = 0.584), and inappropriate shocks (HR 0.92, 95% CI 0.23–3.48, p = 0.902). Non-infectious complications occurred numerically more often in obese patients (16.7% vs. 4.9%, p = 0.058), while device-associated infections were more frequent among non-obese patients (7.4% vs. 0%, p = 0.188). The risk of all-cause mortality (HR 0.32; 95% CI 0.11–0.97; p = 0.141), device-related (HR 0.52; 95% CI 0.14–1.90; p = 0.395) or cardiac rehospitalization (HR 1.06; 95% CI 0.48–2.32; p = 0.890) were similar between the groups.

Conclusion

Despite higher shock impedance during DFT at S-ICD implantation, shock efficacy remained stable during implantation and follow-up in both groups. Fewer infectious but more system-specific complications may manifest in patients with obesity compared to non-obese patients. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableObesityRegistriesElectric CountershockDeath, Sudden, CardiacArrhythmias, CardiacHumansRetrospective StudiesMaleFemaleMiddle AgedBody Mass IndexAgedTreatment OutcomeFollow-Up StudiesRisk Factors

Stichwörter der Autor:innen

DFTDevice therapyDevice-related complicationsObesityS-ICD

Autor:innen und Institutionen

  • Department of Cardiology, Goethe University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
  • Cardiology Center, Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Endocrinology and Diabetology Center, Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • Department of Cardiac Surgery, Goethe University Hospital, Frankfurt am Main, Germany.
  • Department of Cardiology, Goethe University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. erath-honold@med.uni-frankfurt.de.

Förderung

  • none
  • Johann Wolfgang Goethe-Universität, Frankfurt am Main

Zitieren

APA

Gold, C., Gausz, F. D., Vagvolgyi, A., Hecker, F., Kupusovic, J., Miklos, M., Szili-Torok, T., Leistner, D. M., Wakili, R., Erath, J. W., & Vamos, M. (2025). Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02834-x

Vancouver

Gold C, Gausz FD, Vagvolgyi A, Hecker F, Kupusovic J, Miklos M, et al. Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-025-02834-x

BibTeX
@article{Gold2025,
  author = {Gold, Christian and Gausz, Flora Diana and Vagvolgyi, Anna and Hecker, Florian and Kupusovic, Jana and Miklos, Marton and Szili-Torok, Tamas and Leistner, David M and Wakili, Reza and Erath, Julia W and Vamos, Mate},
  title = {Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-025-02834-x}
}
Kostenlos starten →